EOFlow Officially Launches iOS Version of the EOPatch App ‘Narsha’
EOFlow Announces Record Revenue for First Quarter 2022; Revenue of 949 Million KRW which is 137% of Last Year’s Annual Revenue
EOFlow Has its First Clinical Study on EOPatch Published in Diabetes & Metabolism Journal
EOFlow to Supply KRW48.8bn Worth of EOPatch to Gulf Drug of UAE
EOPatch awarded GD (Good Design) designation
Luis Malave joins as new president of EOFLOW
Dr. David Klonoff joins as a Scientific Advisory Board member
Dr. Jonathan Woo joins EOFLOW as CSO
Luis Malave joins as a new board member of EOFLOW
EOFLOW signs up HUONS as distribution partner for Korea
EOFLOW sets up a US subsidiary
EOFLOW will be at the 2017 EASD, Lisbon (9/11-15)
EOPatch submitted for KFDS regulatory approval
EOFLOW featured in a magazine